Xolair auto-injectors exposed to temperatures outside labeled storage requirements
Xolair (omalizumab injection) 150 mg/mL auto-injectors are being recalled because of CGMP deviations: the product was exposed to temperatures outside its labeled storage requirements. 6 units affected.
- Product
- XOLAIR — XOLAIR (OMALIZUMAB)
- Category
- Drug
- Distribution
- Distributed nationwide